Alamifovir

N/A

Report date: 2022/12/07 17:15:12
NME

Base Information

Drug NameAlamifovir
Drug Alias Name阿米福韦MCC-478LY-582563
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHBV DNA Polymerase modulators
TargetsHBV DNA Polymerase
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesMitsubishi Pharma CorpMitsubishi Tanabe Pharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesLilly Suzhou Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A